Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (81)
- Legislation (15)
- Committees and advisory bodies (12)
- Labelling and packaging (7)
- Manufacturing (7)
- Safety monitoring and information (5)
- Advertising (3)
- Fees and payments (3)
- Import and export (3)
- Shortages and supply disruptions (3)
- Sunscreens (3)
- Medicinal cannabis hub (2)
- Clinical trials (1)
- Compliance and enforcement (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
9 result(s) found, displaying 1 to 9
-
ConsultationWe are seeking feedback on whether 19 international scientific guidelines should be adopted.
-
ConsultationThe TGA sought feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.
-
Consultation: Proposed exposure model for assessing the safety of sunscreen ingredients in Australia
ConsultationHave your say on best way to estimate sunscreen use in Australia. Your feedback will be used to calculate the safe concentration of sunscreen ingredients. -
ConsultationHave your say about proposed changes to address 3 medicine safety matters needing action, before we review labelling rules more broadly.
-
ConsultationWe sought feedback on the proposed new ‘Guidelines for the Quality of Listed Probiotic Medicines’.
-
ConsultationThe TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023
-
ConsultationThe outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published
-
ConsultationConsultation: Permissible ingredients annual changes 2020-21
-
ConsultationThese proposed ingredient changes have been reviewed and categorised as being of low-negligible risk. Closing date: 11 October 2019